Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia

Cited by (334)

Items 101–200 of 334

1. Microglial phagocytosis in Alzheimer disease
   Brown, Guy C., St George-Hyslop, Peter, Paolicelli, Rosa C., Lemke, Greg · 2026 · Nature Reviews Neurology
2. APOE ε4 genotype, amyloid-β, and sex interact to predict tau in regions of high APOE mRNA expression
   Aylin Dincer, Charles D. Chen, Nicole Sarah McKay, Lauren N. Koenig, Austin A. McCullough, Shaney E. Flores, Sarah Keefe, Stephanie A. Schultz, Rebecca L. Feldman, Nelly Joseph‐Mathurin et al. · 2022 · Science Translational Medicine
3. Reducing PDK1/Akt Activity: An Effective Therapeutic Target in the Treatment of Alzheimer’s Disease
   Shaobin Yang, Yaqin Du, Xiaoqian Zhao, Chendong Wu, Peng Yu · 2022 · Cells
4. Neuroimmune mechanisms underlying Alzheimer’s disease: Insights into central and peripheral immune cell crosstalk
   Yuqing Liu, Yejun Tan, Zheyu Zhang, Hongli Li, Min Yi, Zhen Zhang, Shan Hui, Weijun Peng · 2022 · Ageing Research Reviews
5. From Physiology to Pathology of Astrocytes: Highlighting Their Potential as Therapeutic Targets for CNS Injury
   Yimin Yuan, Hong Liu, Ziwei Dai, Cheng He, Shangyao Qin, Zhida Su · 2024 · Neuroscience Bulletin
6. APOE from astrocytes restores Alzheimer’s Aβ-pathology and DAM-like responses in APOE deficient microglia
   Preman, Pranav, Moechars, Daan, Fertan, Emre, Wolfs, Leen, Serneels, Lutgarde, Shah, Disha, Lamote, Jochen, Poovathingal, Suresh, Snellinx, An, Mancuso, Renzo et al. · 2024 · EMBO Molecular Medicine
7. The potential role of cholesterol in Parkinson’s disease neuropathology: perpetrator or victim
   Mohammed Alrouji, Hayder Mutter Al-Kuraishy, Abdul-karim Abd Ali Al-Mahammadawy, Ali Ismail Al-Gareeb, ‏Hebatallah M. Saad, Gaber El‐Saber Batiha · 2023 · Neurological Sciences
8. Navigating the metabolic maze: anomalies in fatty acid and cholesterol processes in Alzheimer’s astrocytes
   Xiaoyu Zhang, Chuanying Chen, Yi Liu · 2024 · Alzheimer s Research & Therapy
9. Current understanding of the interactions between metal ions and Apolipoprotein E in Alzheimer’s disease
   Yanhui Zhang, Huiling Gao, Wei Zheng, He Jax Xu · 2022 · Neurobiology of Disease
10. APOE Peripheral and Brain Impact: APOE4 Carriers Accelerate Their Alzheimer Continuum and Have a High Risk of Suicide in PM2.5 Polluted Cities
    Lilian Calderón‐Garcidueñas, Jacqueline Hernández-Luna, Mario Aiello-Mora, Rafael Brito-Aguilar, Pablo Evelson, Rodolfo Villarreal-Ríos, Ricardo Torres‐Jardón, Alberto Ayala, Partha S. Mukherjee · 2023 · Biomolecules
11. Parenchymal border macrophages regulate tau pathology and tau-mediated neurodegeneration
    Antoine Drieu, Siling Du, Michal Kipnis, Megan E. Bosch, Jasmin Herz, Choonghee Lee, Hong Jiang, Melissa Manis, Jason D. Ulrich, Jonathan Kipnis et al. · 2023 · Life Science Alliance
12. Preserving cognitive function in patients with Alzheimer's disease: The Alzheimer's disease neuroprotection research initiative (ADNRI)
    Jie Liu, Heleen M.M. van Beusekom, Xian‐Le Bu, Gong Chen, Paulo Henrique Rosado-de-Castro, Xiaochun Chen, Xiaowei Chen, Andrew N. Clarkson, Tracy D. Farr, YuHong Fu et al. · 2023 · Neuroprotection/Neuroprotection (Chichester, England. Print)
13. Cholesterol Metabolism in Neurodegenerative Diseases
    Keqiang He, Zhiwei Zhao, Juan Zhang, Ding-Feng Li, Sheng Wang, Qiang Liu · 2024 · Antioxidants and Redox Signaling
14. The Therapeutic and Diagnostic Potential of Amyloid β Oligomers Selective Antibodies to Treat Alzheimer’s Disease
    Kirsten L. Viola, Maira Assunção Bicca, Adrian M. Bebenek, Daniel L. Kranz, Vikas Nandwana, Emily Alexandria Waters, Chad R. Haney, Maxwell Y Lee, Abhay Gupta, Zachary Brahmbhatt et al. · 2022 · Frontiers in Neuroscience
15. Single-nucleus RNA sequencing demonstrates an autosomal dominant Alzheimer’s disease profile and possible mechanisms of disease protection
    Maria Camila Almeida, Sarah J. Eger, C. He, Morgane Audouard, Arina A. Nikitina, Stella M.K. Glasauer, Dasol Han, Bárbara Mejía‐Cupajita, Juliana Acosta‐Uribe, Nelson David Villalba‐Moreno et al. · 2024 · Neuron
16. Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer’s disease?
    Vecchio, Filomena Lo, Bisceglia, Paola, Imbimbo, Bruno Pietro, Lozupone, Madia, Latino, Raffaela Rita, Resta, Emanuela, Leone, Maurizio, Solfrizzi, Vincenzo, Greco, Antonio, Daniele, Antonio et al. · 2022 · Therapeutic Advances in Chronic Disease
17. Virus-induced brain pathology and the neuroinflammation-inflammation continuum: the neurochemists view
    Jeswinder Sian‐Hülsmann, Peter Franz Riederer · 2024 · Journal of Neural Transmission
18. The influence of APOEε4 on the pTau interactome in sporadic Alzheimer’s disease
    Manon Thierry, Jackeline Ponce, Mitchell Martá-Ariza, Manor Askenazi, Arline Faustin, Dominique Leitner, Geoffrey Pires, Evgeny Kanshin, Eleanor Drummond, Beatrix M. Ueberheide et al. · 2024 · Acta Neuropathologica
19. All roads lead to heterogeneity: The complex involvement of astrocytes and microglia in the pathogenesis of Alzheimer’s disease
    Marie‐Kim St‐Pierre, Jared VanderZwaag, Sophia M. Loewen, Marie‐Ève Tremblay · 2022 · Frontiers in Cellular Neuroscience
20. Selective removal of astrocytic PERK protects against glymphatic impairment and decreases toxic aggregation of β-amyloid and tau
    Kai Chen, Yosuke M. Morizawa, Tal Nuriel, Osama Al‐Dalahmah, Zhongcong Xie, Guang Yang · 2025 · Neuron
21. <scp>ApoE4</scp> expression disrupts tau uptake, trafficking, and clearance in astrocytes
    Eisenbaum, Maxwell, Pearson, Andrew, Ortiz, Camila, Mullan, Michael, Crawford, Fiona, Ojo, Joseph, Bachmeier, Corbin · 2024 · Glia
22. Nanocarrier-based targeted drug delivery for Alzheimer’s disease: addressing neuroinflammation and enhancing clinical translation
    Wang, Kang, Yang, Rongying, Li, Jing, Wang, Haitao, Wan, Li, He, Jiale · 2025 · Frontiers in Pharmacology
23. Autism-associated CHD8 controls reactive gliosis and neuroinflammation via remodeling chromatin in astrocytes
    Platon Megagiannis, Mei Yuan, Rachel Yan, Lin Yuan, Jonathan J. Wilde, Hailey Eckersberg, Rahul Suresh, Xinzhu Tan, Hong Chen, William Todd Farmer et al. · 2024 · Cell Reports
24. The glymphatic system in neurodegenerative diseases and brain tumors: mechanistic insights, biomarker advances, and therapeutic opportunities
    Liyun Jia, Yue Chen, Hengzeng Li, Kai Zhao, Shuo Ge, Cong Wang, Jiayuan Zhao, Feifei Li, Leilei Zhang, Anhui Yao · 2025 · Acta Neuropathologica Communications
25. Does the imbalance in the apolipoprotein E isoforms underlie the pathophysiological process of sporadic Alzheimer's disease?
    Madia Lozupone, Bruno Pietro Imbimbo, Claudia Balducci, Filomena Lo Vecchio, Paola Bisceglia, Raffaela Rita Latino, Maurizio Angelo Leone, Vittorio Dibello, Vincenzo Solfrizzi, Antonio Greco et al. · 2022 · Alzheimer s & Dementia
26. Molecular Insights into Cell Type-specific Roles in Alzheimer’s Disease: Human Induced Pluripotent Stem Cell-based Disease Modelling
    Wenhui Qu, Peter Canoll, Gunnar Hargus · 2022 · Neuroscience
27. TREM2 bridges microglia and extracellular microenvironment: Mechanistic landscape and therapeutical prospects on Alzheimer’s disease
    Yiheng Zhao, Qian Guo, Jia Tian, Wei Liu, Xiaochuan Wang · 2024 · Ageing Research Reviews
28. Identifying differential regulatory control of APOE ɛ4 on African versus European haplotypes as potential therapeutic targets
    Karen Nuytemans, Marina Lipkin Vasquez, Liyong Wang, Derek Van Booven, Antony J. Griswold, Farid Rajabli, Katrina Celis, Oded Oron, Natalia K. Hofmann, Sophie Rolati et al. · 2022 · Alzheimer s & Dementia
29. The APOE–Microglia Axis in Alzheimer’s Disease: Functional Divergence and Therapeutic Perspectives—A Narrative Review
    Aiwei Liu, Tingyue Wang, Liu Yang, Yu Zhou · 2025 · Brain Sciences
30. Astrocytes in Neurodegenerative Diseases: A Perspective from Tauopathy and α-Synucleinopathy
    Peng Wang, Yihong Ye · 2021 · Life
31. APOEε4 and risk of Alzheimer’s disease – time to move forward
    Iliya M. Lefterov, Nicholas Francis Fitz, Yi Lü, Radosveta P. Koldamova · 2023 · Frontiers in Neuroscience
32. The Single Toxin Origin of Alzheimer’s Disease and Other Neurodegenerative Disorders Enables Targeted Approach to Treatment and Prevention
    Martin Tolar, John A. Hey, Aidan Power, Susan R. Abushakra · 2024 · International Journal of Molecular Sciences
33. Failure in a population: Tauopathy disrupts homeostatic set-points in emergent dynamics despite stability in the constituent neurons
    James N. McGregor, Clayton A. Farris, Sahara Ensley, Aidan M Schneider, Leandro J. Fosque, Chao Wang, Elizabeth I. Tilden, Yuqi Liu, Jianhong Tu, Halla Elmore et al. · 2024 · Neuron
34. Innate and adaptive immunity in neurodegenerative disease
    Yeyu Huang, Guoxin Zhang, Sheng Li, Jin Feng, Zhentao Zhang · 2025 · Cellular and Molecular Life Sciences
35. Impact of APOE genotype on prion-type propagation of tauopathy
    Tristan Williams, Alejandra Jolie Ruiz, Angelica Maria Ruiz, Quan Vo, Wangchen Tsering, Guilian M. Xu, Karen N. McFarland, Benoit I. Giasson, Patrick M. Sullivan, David Borchelt et al. · 2022 · Acta Neuropathologica Communications
36. Microglia sense astrocyte dysfunction and prevent disease progression in an Alexander disease model
    Kozo Saito, Eiji Shigetomi, Youichi Shinozaki, Kenji Kobayashi, Bijay Parajuli, Yuto Kubota, Kent Sakai, Miho Miyakawa, Hiroshi Horiuchi, Junichi Nabekura et al. · 2023 · Brain
37. APOE4/4 is linked to damaging lipid droplets in Alzheimer’s microglia
    Haney, Michael S., Pálovics, Róbert, Munson, Christy Nicole, Long, Chris, Johansson, Patrik, Yip, Oscar, Dong, Wentao, Rawat, Eshaan, West, Elizabeth, Schlachetzki, Johannes CM et al. · 2023
38. Enhancer-AAVs allow genetic access to oligodendrocytes and diverse populations of astrocytes across species
    John K. Mich, Smrithi Sunil, Nelson Johansen, Refugio A. Martinez, Jiatai Liu, Bryan B. Gore, Joseph T. Mahoney, Mckaila Leytze, Yoav Ben‐Simon, Darren Bertagnolli et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
39. Current insights into apolipoprotein E and the immune response in Alzheimer's disease
    Lin, Peter Bor‐Chian, Holtzman, David M. · 2024 · Immunological Reviews
40. Cholesterol Metabolism in CNS Diseases: The Potential of SREBP2 and LXR as Therapeutic Targets
    Wang, Ning-Qi, Sun, Pei-Xiang, Shen, Qi-Qi, Deng, Meng-Yan · 2025 · Molecular Neurobiology
41. Evidence that Alzheimer’s Disease Is a Disease of Competitive Synaptic Plasticity Gone Awry
    Zhen Huang · 2024 · Journal of Alzheimer s Disease
42. New insights into innate immunity in Alzheimer’s disease: From APOE protective variants to therapies
    Chen, Yun, Holtzman, David M. · 2024 · Trends in Immunology
43. APOE4 to APOE2 allelic switching in mice improves Alzheimer’s disease-related metabolic signatures, neuropathology and cognition
    Golden, Lesley R., Siano, Dahlia S., Stephens, Isaiah O., MacLean, Steven M., Saito, Kai, Nolt, Georgia L., Funnell, Jessica L., Pallerla, Akhil V., Lee, Sangderk, Smith, Cathryn et al. · 2025 · Nature Neuroscience
44. As a Potential Therapeutic Target, C1q Induces Synapse Loss Via Inflammasome-activating Apoptotic and Mitochondria Impairment Mechanisms in Alzheimer’s Disease
    Pei-Pei Guan, Tong-Qi Ge, Pu Wang · 2023 · Journal of Neuroimmune Pharmacology
45. Alzheimer’s disease: an axonal injury disease?
    Dan Liang, Zhaohui Zhang · 2023 · Frontiers in Aging Neuroscience
46. Minding the Gap: Exploring Neuroinflammatory and Microglial Sex Differences in Alzheimer’s Disease
    Erin G. Reed-Geaghan, Phaedra R. Keller-Norrell · 2023 · International Journal of Molecular Sciences
47. Synergism of ApoE4 and systemic infectious burden is mediated by the APOE ‐ NLRP3 axis in Alzheimer's disease
    Xueting Liu, Chen Xiu, Na Zhao, Fan Geng, Meng‐Meng Zhu, Qingguo Ren · 2024 · Psychiatry and Clinical Neurosciences
48. Repetitive head trauma and apoE4 induce chronic cerebrovascular alterations that impair tau elimination from the brain
    Maxwell Eisenbaum, Andrew Pearson, Camila Ortiz, Milica Koprivica, Arianna Cembran, MICHAEL J. MULLAN, Fiona Crawford, Joseph O. Ojo, Corbin J. Bachmeier · 2024 · Experimental Neurology
49. Astrocytes Lingering at a Crossroads: Neuroprotection and Neurodegeneration in Neurocognitive Dysfunction
    Xiaoxia Xu, Bin Mei, Yue Yang, Junxiong Li, Juntao Weng, Yueyue Yang, Qianyun Zhu, Honghai Zhang, Xuesheng Liu · 2025 · International Journal of Biological Sciences
50. APOE4-driven lipid metabolic dysregulation in Alzheimer's disease: Multi-pathway mechanisms and therapeutic perspectives
    Wen-Xuan Zhang, Yi-Liang Yang, Jiaxin Yu, Lihong Jia, Han‐Chang Huang · 2025 · Biochemical and Biophysical Research Communications
51. APOE4 genotype and aging impair injury-induced microglial behavior in brain slices, including toward Aβ, through P2RY12
    Jordy Sepulveda, Jennifer Yejean Kim, Joseph Binder, Stefano Vicini, George William Rebeck · 2024 · Molecular Neurodegeneration
52. Immunological aspects of central neurodegeneration
    Mireia Niso‐Santano, José Manuel Fuentes, Lorenzo Galluzzi · 2024 · Cell Discovery
53. The cross-talk between ApoE and Tau protein in Alzheimer’s disease
    Subashchandrabose Chinnathambi, Murugappan Kumarappan, Madhura Chandrashekar · 2024 · Advances in protein chemistry and structural biology
54. Astrocyte Lipid Droplet Dynamics Orchestrate Neurological Disorders and Therapeutic Horizons
    Jiani Zhong, Yanyi Peng, Lingyue Zhang, Bo Xiao, Mengqi Zhang · 2025 · Small Science
55. Relationship of Apolipoprotein E with Alzheimer’s Disease and Other Neurological Disorders: An Updated Review
    Tian-Wen Lou, Borui Tao, Ming Chen · 2023 · Neuroscience
56. Positron Emission Tomography in Animal Models of Tauopathies
    Lei Cao, Yanyan Kong, Bin Ji, Yutong Ren, Yihui Guan, Ruiqing Ni · 2022 · Frontiers in Aging Neuroscience
57. Absence of Apolipoprotein E is associated with exacerbation of prion pathology and promotes microglial neurodegenerative phenotype
    Pankiewicz, Joanna E., Lizińczyk, Anita M., Franco, Leor A., Diaz, Jenny R., Martá-Ariza, Mitchell, Sadowski, Martin J. · 2021 · Acta Neuropathologica Communications
58. The glymphatic system as a therapeutic target: TMS-induced modulation in older adults
    Mark Sundman, Yilin Liu, Nan‐kuei Chen, Ying‐hui Chou · 2025 · Frontiers in Aging Neuroscience
59. Mechanisms of high-density lipoprotein in regulating blood-brain barrier function: insights and implications
    Pengxi Zhu, Liyao Xiao, Yijie Wang · 2025 · Fluids and Barriers of the CNS
60. Microglial Modulation in Alzheimer’s Disease: Central Players in Neuroinflammation and Pathogenesis
    Md Sadique Hussain, Yumna Khan, Rabab Fatima, Mudasir Maqbool, Prasanna Srinivasan Ramalingam, Mohammad Gayoor Khan, Ajay Singh Bisht · 2025 · Current Alzheimer Research
61. Refining the interactions between microglia and astrocytes in Alzheimer’s disease pathology
    Jiangmin Chen, Shuyu Xu, Li Wang, Xinyuan Liu, Guangya Liu, Qian Tan, Weixian Li, Shuai Zhang, Yanjun Du · 2025 · Neuroscience
62. Single-nucleus chromatin accessibility profiling highlights distinct astrocyte signatures in progressive supranuclear palsy and corticobasal degeneration
    Nils Briel, Viktoria Ruf, Katrin Pratsch, Sigrun Roeber, Jeannine Widmann, Janina Mielke, Mario M. Dorostkar, Otto Windl, Thomas Arzberger, Jochen Wolfgang Herms et al. · 2022 · Acta Neuropathologica
63. Humanized APOE genotypes influence lifespan independently of tau aggregation in the P301S mouse model of tauopathy
    Tristan Williams, Tim Bathe, Quan Vo, Patricia Sacilotto, Karen N. McFarland, Alejandra Jolie Ruiz, Gabriela P. Hery, Patrick M. Sullivan, David Borchelt, Stefan Prokop et al. · 2023 · Acta Neuropathologica Communications
64. Alzheimer’s disease and immunotherapy
    Wei Qin, Yana Pang, Shuya Nie, Meina Quan, Jianping Jia · 2024 · Current Medicine
65. Alzheimer’s Disease and Impaired Bone Microarchitecture, Regeneration and Potential Genetic Links
    Min Zhang, Shunze Hu, Xuying Sun · 2023 · Life
66. GSK ‐3β activation mediates apolipoprotein E4 ‐associated cognitive impairment in type 2 diabetes mellitus: A multicenter, cross‐sectional study
    Yang Gao, Haitao Yu, Yanchao Liu, Zhipeng Xu, Benrong He, Benrong He, Yuying Wang, Yao Zhang, Yi Liang, Fei Sun et al. · 2022 · Journal of Diabetes
67. Spatiotemporal Dynamics of Central Nervous System Diseases: Advancing Translational Neuropathology via Single‐Cell and Spatial Multiomics
    Mingkai Xia, Quan Liu, Wenli Zhang, Jinwen Ge, Zhigang Mei · 2025 · MedComm
68. ApoE-calypse tau: ApoE–tau synergy in Alzheimer’s disease
    Matthew Paul Lennol, Chiara Bordier, Léana Kamelher, Jason D. Ulrich, David M. Holtzman, Maud Gratuze · 2025 · The Journal of Experimental Medicine
69. Exploring the Role of Lipid-Binding Proteins and Oxidative Stress in Neurodegenerative Disorders: A Focus on the Neuroprotective Effects of Nutraceutical Supplementation and Physical Exercise
    Giorgia Scarfò, Rebecca Piccarducci, Simona Daniele, Ferdinando Franzoni, Claudia Martini · 2022 · Antioxidants
70. Bridging immune-neurovascular crosstalk via the immunomodulatory microspheres for promoting neural repair
    Tongtong Xu, Lin Gan, Wei Chen, Dandan Zheng, Hanlai Li, Shiyu Deng, Dongliang Qian, Tingting Gu, Qianyuan Lian, Gracie Shen et al. · 2024 · Bioactive Materials
71. Inhaled xenon modulates microglia and ameliorates disease in mouse models of amyloidosis and tauopathy
    Wesley Nogueira Brandão, Nimansha Jain, Zhuoran Yin, Kilian L. Kleemann, Madison Carpenter, Xin Bao, Javier Remolina Serrano, Eric Tycksen, Ana Carolina Cardoso dos Santos Durão, Jen‐Li Barry et al. · 2025 · Science Translational Medicine
72. The Lipid Invasion Model: Growing Evidence for This New Explanation of Alzheimer’s Disease
    Jonathan D’Arcy Rudge · 2023 · Journal of Alzheimer s Disease
73. Unknown roles of tau pathology in neurological disorders. Challenges and new perspectives
    Margrethe A. Olesen, Francisca Villavicencio-Tejo, Victor Cuevas-Espinoza, Rodrigo A. Quintanilla · 2024 · Ageing Research Reviews
74. Cytoskeletal control in adult microglia is essential to restore neurodevelopmental synaptic and cognitive deficits
    Sofie Kessels, Chloë Trippaers, Melanie Mertens, Ibrahim Hamad, Ben Rombaut, Art Janssen, Keerthana Ramanathan, Sam Duwé, Adelaïde M. Gharghani, Rune Theuwis et al. · 2025 · Science Advances
75. PathFinder: a novel graph transformer model to infer multi-cell intra- and inter-cellular signaling pathways and communications
    Jiarui Feng, Haoran Song, Michael A. Province, Guangfu Li, Philip Payne, Yixin Chen, Fuhai Li · 2024 · Frontiers in Cellular Neuroscience
76. Variable and interactive effects of Sex, APOE ε4 and TREM2 on the deposition of tau in entorhinal and neocortical regions
    Joseph Giorgio, Caroline Jonson, Yilin Wang, Jennifer S. Yokoyama, Jingshen Wang, William J. Jagust, On behalf of the Alzheimer’s Disease Neuroimaging Initiative · 2025 · Nature Communications
77. Tau propagation is dependent on the genetic background of mouse strains
    Dujardin, Simon, Fernandes, Analiese, Bannon, Riley, Commins, Caitlin, De Los Santos, Mark, Kamath, Tarun V., Hayashi, Mansuo, Hyman, Bradley T. · 2022 · Brain Communications
78. Innovations advancing our understanding of microglia in Alzheimer's disease: From in vitro to in vivo models
    Simon Maksour, Lezanne Ooi · 2023 · Journal of Neurochemistry
79. Morphofunctional Investigation in a Transgenic Mouse Model of Alzheimer’s Disease: Non-Reactive Astrocytes Are Involved in Aβ Load and Reactive Astrocytes in Plaque Build-Up
    Daniele Lana, Jacopo Junio Valerio Branca, Giovanni Delfino, Maria Grazia Giovannini, Fiorella Casamenti, Pamela Nardiello, Monica Bucciantini, Massimo Stefani, Petr Zach, Sandra Zecchi‐Orlandini et al. · 2023 · Cells
80. An mTOR-independent Macroautophagy Activator Ameliorates Tauopathy and Prionopathy Neurodegeneration Phenotypes
    Leonard Yoon, Rachel C. Botham, Adriaan Verhelle, Yin Wu, Christian M. Cole, Ee Phie Tan, Lynée A. Massey, Pablo Sanz-Martinez, Ching‐Chieh Chou, Jin Xu et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
81. Regulation of neuroinflammation by astrocyte-derived cholesterol
    Hao Wang, Joshua A. Kulas, Yang Yu, Joshua L. Milstein, Claire E. Peng, Holden Higginbotham, Jed Robert Christensen, Michael A. Kovacs, Anton M. Schüle, Denys Oliinyk et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
82. Spatial heterogeneity in microglia‐complement crosstalk: Implications for synaptic pruning in Alzheimer's disease
    Qiuyan Ye, Wei Gao, Jiaping Feng, Xue Li, Jianhui Li, Fengge Yang, Linqing Li, Mingsheng Zi, Xinkai Wu, Hainan Gao et al. · 2026 · Alzheimer s & Dementia
83. Microglial Responses to Alzheimer's Disease Pathology: Insights From “Omics” Studies
    Aquene N. Reid, Suman Jayadev, Katherine E. Prater · 2025 · Glia
84. Reduced synaptic vesicle protein 2A in extracellular vesicles and brains of Alzheimer’s disease: associations with Aβ, tau, synaptic proteins and APOE ε4
    Jana Nussbaumer, Aatmika Barve, Valentin Zufferey, Jeanne Espourteille, Tunahan Kirabali, Uwe Konietzko, Daniel Razansky, Axel Rominger, Agneta K. Nordberg, Luc Buée et al. · 2025 · Translational Neurodegeneration
85. Comparing RNA ‐sequencing datasets from astrocytes, oligodendrocytes, and microglia in multiple sclerosis identifies novel dysregulated genes relevant to inflammation and myelination
    Sienna Drake, Aliyah Zaman, Tristan Simas, Alyson E. Fournier · 2023 · WIREs Mechanisms of Disease
86. Lysosomal transmembrane protein 5: Impact on immune cell function and implications for immune-related deficiencies
    Pengpeng Sun, Shi‐Xia Liao, Peng Sang, Maomao Liu, Ji-Bin Yang · 2024 · Heliyon
87. Therapeutic approaches to microglial dysfunction in Alzheimer's disease: Enhancing phagocytosis and metabolic regulation
    Waleed Hassan Almalki, Salem Salman Almujri · 2024 · Pathology - Research and Practice
88. Rodent models of Alzheimer's disease: Critical analysis of current hypotheses and pathways for future research
    Pasindu Hansana Singhaarachchi, Péter Antal, Frédéric Calon, Carsten Culmsee, Jean-Christophe Delpech, Martin Feldotto, Jorine Geertsema, Emmy E. Hoeksema, Anikó Kőrösi, Sophie Layé et al. · 2025 · Progress in Neurobiology
89. Astrocytes as Therapeutic Targets in Neurodegenerative Disorders
    Isabel H. Salas, María Alfonso-Triguero, Blanca Díaz Castro, Nimrod Elazar, Carole Escartin, Camilo Faust Akl, Steven A. Hill, Francisco Javier Quintana, Amaia M. Arranz · 2025 · Journal of Neuroscience
90. The role of astrocytes in Alzheimer's disease: Pathophysiology, biomarkers, and therapeutic potential
    Md. Joynal Abedin, Ksenia V. Kastanenka · 2026 · Journal of Alzheimer s Disease
91. Inducible deletion of DGAT1 and 2 from microglia exacerbates neurodegeneration and endolysosomal lipid accumulation in male PS19 mice
    G. Travis Tabor, Alexandra Litvinchuk, Yun Chen, Austin Allison, Elizabeth Wen Sun, Bettina van Lengerich, Sonnet S. Davis, Elizabeth West, Johannes C. M. Schlachetzki, Carisa Zeng et al. · 2026 · Cell Reports
92. Brain region-specific myelinogenesis is not directly linked to amyloid-β in APP/PS1 transgenic mice
    Shuang-Ling Wu, Bin Yu, Yong-Jie Cheng, Shu-Yu Ren, Fei Wang, Lan Xiao, Jing‐Fei Chen, Feng Mei · 2023 · Experimental Neurology
93. DLK-MAPK Signaling Coupled with DNA Damage Promotes Intrinsic Neurotoxicity Associated with Non-Mutated Tau
    Sanming Li, Ethan R. Roy, Yanyu Wang, Trent A. Watkins, Wei Cao · 2023 · Molecular Neurobiology
94. Diverse influences on tau aggregation and implications for disease progression
    Meaghan Van Alstyne, James Pratt, Roy Parker · 2025 · Genes & Development
95. Focused ultrasound‐mediated <i>APOE4</i> knockdown in mouse brain
    Zheng, Kaiyuan, Tsitsos, Fotios N., Batts, Alec J., Ji, Robin, Nuriel, Tal, Konofagou, Elisa E., Leong, Kam W. · 2025 · Alzheimer's &amp; Dementia
96. Identifying pathogenic variants associated with Alzeimer by integrating genomic databases and bioinformatics approaches
    D. Amukti, Annisa Rizqita Wazni, L. Irham, N. Sulistyani, Muhammad Ma'ruf, W. Adikusuma, Made Ary Sarasmita, S. Khairi, B. Purwanto, Suyatmi Suyatmi et al. · 2024 · E3S Web of Conferences
97. Distinct factors drive the progression of tau pathology in Alzheimer’s disease
    Yifan Luo, Honglu Yu, Keqiang Ye · 2025 · Fundamental Research
98. The dual role of microglia in neurodegenerative diseases: A review
    Nanke Zhang, Nan Xiong, Yanlin He, Lele Zhou · 2026 · Brain Research Bulletin
99. Recent advances in Alzheimer’s disease: From molecular mechanisms to therapeutic strategies
    Michelle Diane Rudman, Jason D. Ulrich, David M. Holtzman · 2026 · Cell
100. Exercise modulates APOE expression in brain cortex of female APOE3 and APOE4 targeted replacement mice
     Verona E Mulgrave, Abdulrahman Ahmed Alsayegh, Aida Jaldi, Diannemarie Omire-Mayor, Niaya James, Oyonumo E. Ntekim, Eric Walters, Emmanuel O. Akala, Joanne S. Allard · 2022 · Neuropeptides